Twist Bioscience Corp. (TWST)
140.74
-4.85
(-3.33%)
USD |
NASDAQ |
Aug 24, 16:00
138.00
-2.74
(-1.95%)
After-Hours: 19:54
Twist Bioscience Price to Book Value : 19.79 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 20.47 |
| August 20, 2026 | 19.17 |
| August 19, 2026 | 20.02 |
| August 18, 2026 | 16.32 |
| August 17, 2026 | 17.49 |
| August 14, 2026 | 16.67 |
| August 13, 2026 | 17.62 |
| August 12, 2026 | 17.61 |
| August 11, 2026 | 17.31 |
| August 10, 2026 | 17.56 |
| August 07, 2026 | 16.26 |
| August 06, 2026 | 15.34 |
| August 05, 2026 | 16.17 |
| August 04, 2026 | 13.98 |
| August 03, 2026 | 14.21 |
| July 31, 2026 | 12.87 |
| July 30, 2026 | 12.84 |
| July 29, 2026 | 12.02 |
| July 28, 2026 | 12.45 |
| July 27, 2026 | 12.17 |
| July 24, 2026 | 12.69 |
| July 23, 2026 | 13.00 |
| July 22, 2026 | 13.25 |
| July 21, 2026 | 13.48 |
| July 20, 2026 | 12.30 |
| Date | Value |
|---|---|
| July 17, 2026 | 13.20 |
| July 16, 2026 | 12.83 |
| July 15, 2026 | 13.02 |
| July 14, 2026 | 13.01 |
| July 13, 2026 | 12.70 |
| July 10, 2026 | 12.74 |
| July 09, 2026 | 13.17 |
| July 08, 2026 | 12.57 |
| July 07, 2026 | 12.80 |
| July 06, 2026 | 14.05 |
| July 02, 2026 | 13.95 |
| July 01, 2026 | 14.38 |
| June 30, 2026 | 14.47 |
| June 29, 2026 | 13.43 |
| June 26, 2026 | 13.64 |
| June 25, 2026 | 13.20 |
| June 24, 2026 | 12.48 |
| June 23, 2026 | 11.61 |
| June 22, 2026 | 11.63 |
| June 18, 2026 | 11.96 |
| June 17, 2026 | 11.32 |
| June 16, 2026 | 11.60 |
| June 15, 2026 | 11.03 |
| June 12, 2026 | 10.40 |
| June 11, 2026 | 10.11 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Beam Therapeutics, Inc. | 2.742 |
| Prime Medicine, Inc. | 14.78 |
| Intellia Therapeutics, Inc. | 2.415 |
| 10X Genomics, Inc. | 10.07 |
| Generate Biomedicines, Inc. | 4.981 |
Price to Book Value Related Metrics
| PS Ratio | 20.01 |
| PEG Ratio | -1.190 |
| Price | 140.74 |
| Earnings Yield | -1.58% |
| Market Cap | 8.821B |
| PEGY Ratio | -1.190 |